Skip to main content

Animations

MJFF Publications

2831 - 2840 of 6509 Results
Title
Year
  • Year
  • 2023
  • 2021
  • 2024
  • 2024
  • 2024
  • 2024
  • 2025
  • 2023
  • 2023
  • 2024
  • Summary Details
    OPEN
    Title: Long‐Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29610
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Correction: VPS13D bridges the ER to mitochondria and peroxisomes via Miro
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, #VALUE!
    DOI - Digital Object Identifier: 10.1083/jcb.20201000405052021c
    Citation Count: 10
  • Summary Details
    OPEN
    Title: PINK1 is a target of T cell responses in Parkinson’s disease
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1172/jci180478
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-024-01972-8
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traits
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-024-01973-7
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adq3539
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Advice for translational neuroscience: move deliberately and build things
    Journal Name: Bioelectronic Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s42234-025-00165-w
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Impact of deep brain stimulation on gait in Parkinson disease: A kinematic study
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2023.12.002
    Citation Count: 11
  • Summary Details
    OPEN
    Title: DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102414
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14448
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.